Strategy for in vitro cell age validation for a CHO cell line producing a therapeutic monoclonal antibody.

被引:0
|
作者
Moore, AW [1 ]
Trala, R [1 ]
Pennetti, D [1 ]
deVries, RL [1 ]
机构
[1] GlaxoSmithKline, Biopharmaceut Dev, King Of Prussia, PA 19406 USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
211-BIOT
引用
收藏
页码:U233 / U233
页数:1
相关论文
共 50 条
  • [21] Host cell protein dynamics in the supernatant of a mAb producing CHO cell line
    Tait, A. S.
    Hogwood, C. E. M.
    Smales, C. M.
    Bracewell, D. G.
    BIOTECHNOLOGY AND BIOENGINEERING, 2012, 109 (04) : 971 - 982
  • [22] The CHO cell line as a potentially safer host for cetuximab therapeutic antibody production than the Sp2/0 cell line
    Bartusik-Czubek E.E.
    Czubek B.M.
    Toboła P.E.
    Lonkwic K.M.
    Miłek P.P.
    Grzyb O.H.
    Balcerek J.A.
    Pietrucha T.
    Jaros S.
    International Journal of Biotechnology, 2023, 14 (04) : 277 - 292
  • [23] Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform
    Ghorbaniaghdam, Atefeh
    Chen, Jingkui
    Henry, Olivier
    Jolicoeur, Mario
    PLOS ONE, 2014, 9 (03):
  • [24] Metabolomic and quality data for early and late passages of an antibody-producing industrial CHO cell line
    Sowa, Steven W.
    Qian, Yueming
    Aron, Kathryn L.
    Xu, Ping
    Langsdorf, Erik
    Warrack, Bethanne
    Aranibar, Nelly
    Tremml, Gabi
    Xu, Jianlin
    McVey, Duncan
    Reily, Michael
    Khetan, Anurag
    Borys, Michael C.
    Li, Zheng Jian
    DATA IN BRIEF, 2020, 33
  • [25] Evaluation of small scale cell culture methods and production and purification of a monoclonal antibody.
    Park, JT
    Cork, S
    Cao, C
    Coliano, T
    Menking, D
    O'Connell, K
    Valdes, JJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U210 - U210
  • [26] Lipidomics of CHO Cell Bioprocessing: Relation to Cell Growth and Specific Productivity of a Monoclonal Antibody
    Ali, Amr S.
    Raju, Ravali
    Ray, Somak
    Kshirsagar, Rashmi
    Gilbert, Alan
    Zang, Li
    Karger, Barry L.
    BIOTECHNOLOGY JOURNAL, 2018, 13 (10)
  • [27] Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody
    Chromikova, Veronika
    Zaragoza, Maria A.
    Krammer, Florian
    PLOS ONE, 2017, 12 (09):
  • [28] Therapeutic cancer vaccines generated by modification of autologous tumor cells in vitro with cytokines and a bispecific monoclonal antibody.
    Guo, YJ
    Wu, SG
    Zhao, J
    Wang, H
    Liu, YJ
    Xie, TP
    Wei, LX
    He, P
    Shen, F
    Habib, N
    Wu, MC
    HUMAN GENE THERAPY, 1999, 10 (05) : 841 - 841
  • [29] Understanding the generation of monoclonal antibody charge heterogeneity in CHO cell cultures
    Zhang, Xintao
    Tang, Hongping
    Zhao, Liang
    Fan, Li
    Tan, Wen-Song
    Liu, Xuping
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [30] The long term clinical outcome of B cell lymphoma patients treated with anti-idiotype monoclonal antibody correlated with the isotype of the therapeutic antibody.
    Weng, Wen-Kai
    Czerwinski, Debbie
    Levy, Ronald
    BLOOD, 2006, 108 (11) : 208A - 208A